Shares in Shanghai Fosun Pharmaceutical tumbled as much as 12 per cent on their Hong Kong market debut on Tuesday, suggesting a rough ride ahead for Zhengzhou Coal Mining Machinery, the People’s Insurance Company of China and other Chinese groups still hoping to raise money this year.
復星醫藥(Fosun Pharmaceutical)週二在香港股市交易首日，盤中股價一度下跌12%。這預示著，包括鄭州煤礦機械集團(Zhengzhou Coal Mining Machinery)、中國人保(PICC)等數家仍希望於年內在香港融資的中資集團將面臨不平坦的上市之路。
您已閱讀11%（425字），剩餘89%（3446字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。